Expanded Access Program for gallium maltolate (GaM) Now Open
xCures, a healthcare data platform provider, announced that the US Food and Drug Administration (FDA) has approved an Expanded Access Program (EAP) for gallium maltolate (GaM), a new cancer therapy.
